Towards prognostic biomarkers in pulmonary arterial hypertension

Cracowski J-L.

Source: Eur Respir J 2012; 39: 799-801
Journal Issue: April
Disease area: Pulmonary vascular diseases

Full text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Cracowski J-L.. Towards prognostic biomarkers in pulmonary arterial hypertension. Eur Respir J 2012; 39: 799-801

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Determinants and prognostic value of kidney disease in pulmonary arterial hypertension
Source: International Congress 2018 – Clinical aspects of pulmonary hypertension
Year: 2018


Novel biomarkers for risk stratification in pulmonary arterial hypertension
Source: ERJ Open Res 2015; 1: 00008-2015
Year: 2015



Prognostic value of exercise pulmonary haemodynamics in pulmonary arterial hypertension
Source: Eur Respir J 2014; 44: 704-713
Year: 2014



Pulmonary pressure at rest and during slight exercise might have prognostic relevance in patients at risk for pulmonary arterial hypertension
Source: Annual Congress 2008 - Pulmonary arterial hypertension and other pulmonary vascular diseases
Year: 2008


Analysis of the cardiac index-PvO2 relationship during vasodilatation challenge as a prognostic factor in pulmonary arterial hypertension
Source: Annual Congress 2011 - Physiology of human pulmonary hypertension
Year: 2011


Novel biomarkers in idiopathic pulmonary arterial hypertension
Source: Annual Congress 2010 - Pulmonary hypertension
Year: 2010


Ventricular mass as a prognostic imaging biomarker in incident pulmonary arterial hypertension
Source: Eur Respir J, 53 (4) 1802067; 10.1183/13993003.02067-2018
Year: 2019



The long-term prognostic value of extracted thrombus and hemodynamics and in chronic thromboembolic pulmonary hypertension
Source: Annual Congress 2012 - Pulmonary circulation: end-points and biomarkers
Year: 2012

Survival and prognostic factors of acute exacerbations of pulmonary arterial hypertension
Source: Eur Respir J 2007; 30: Suppl. 51, 342s
Year: 2007

Prognostic factors in pulmonary arterial hypertension: assessing the course of the disease
Source: Eur Respir Rev 2011; 20: 236-242
Year: 2011



Prognostic relevance of changes in exercise parameters in pulmonary arterial hypertension
Source: Annual Congress 2012 - Pulmonary circulation: clinical end-points and clinical physiology
Year: 2012

Growth-differentiation factor-15 as a prognostic indicator in idiopathic pulmonary arterial hypertension
Source: Annual Congress 2008 - Pathophysiology of pulmonary hypertension
Year: 2008


Multi-omic profiling in pulmonary arterial hypertension
Source: Virtual Congress 2020 – Genetics and genomics of pulmonary arterial hypertension
Year: 2020




Prognostic value of hemodynamics following treatment initiation in pulmonary arterial hypertension
Source: International Congress 2017 – Cardiac function assessment in pulmonary hypertension
Year: 2017



The future of treatment for pulmonary arterial hypertension
Source: ERS Skills course - Pulmonary hypertension and pulmonary vascular disease
Year: 2018

The future of treatment for pulmonary arterial hypertension
Source: ERS Course 2017 - Pulmonary Hypertension and Pulmonary Vascular Disease
Year: 2017

The future of treatment for pulmonary arterial hypertension
Source: School Course 2014 - Pulmonary Hypertension and Pulmonary Vascular Disease
Year: 2014

The future of treatment for pulmonary arterial hypertension
Source: School Course 2012 - Pulmonary hypertension and pulmonary vascular disease
Year: 2012


Prognostic significance of pulmonary arterial pressure in patients with idiopathic pulmonary fibrosis
Source: Annual Congress 2010 - Clinical aspects in pulmonary fibrosis
Year: 2010